OTR Acquisition 10-K/A 13 Dec 21 2020 FY Annual report (amended) Financial data

Document and Entity Information

Document and Entity Information	5 Months Ended
	Dec. 31, 2020USD ($)shares
Document Information [Line Items]
Document Type	10-K/A
Document Period End Date	Dec. 31, 2020
Document Transition Report	false
Entity Registrant Name	OTR Acquisition Corp.
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	true
Transition Report	true
Entity Central Index Key	0001821318
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	FY
Amendment Flag	true
Document Annual Report	true
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Public Float | $	$ 109,490,843.70
Amendment Description	Amendment No. 2
Class A common stock
Document Information [Line Items]
Title of 12(b) Security	Class A Common Stock, par value $0.0001 per share
Trading Symbol	OTRA
Security Exchange Name	NASDAQ
Entity Common Stock, Shares Outstanding	10,630,179
Class B common stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding	2,611,838
Units, each consisting of one share of Class A Common Stock and one-half of one Redeemable Warrant
Document Information [Line Items]
Title of 12(b) Security	Units, each consisting of one share of Class A Common Stock and one-half of one Redeemable Warrant
Trading Symbol	OTRAU
Security Exchange Name	NASDAQ
Redeemable warrants, each whole warrant exercisable
Document Information [Line Items]
Title of 12(b) Security	Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
Trading Symbol	OTRAW
Security Exchange Name	NASDAQ

BALANCE SHEET

BALANCE SHEET	Dec. 31, 2020USD ($)
Current Assets
Cash	$ 0
Cash	991,720
Prepaid expenses	333,208
Total Current Assets	1,324,928
Cash and marketable securities held in Trust Account	107,094,493
Total Assets	108,419,421
Current Liabilities
Accrued expenses	155,524
Total Current Liabilities	155,524
Deferred underwriting fee payable	3,395,389
Derivative warrant liabilities	11,224,383
Total Liabilities	14,775,296
Commitments and Contingencies
Class A common stock subject to possible redemption; 10,447,350 shares (at approximately $10.25 per share)	107,085,338
Stockholders' Deficit
Accumulated deficit	(13,441,493)
Total Stockholders' Deficit	(13,441,213)
Total Liabilities and Stockholders' Deficit	108,419,421
Class A common stock
Current Liabilities
Class A common stock subject to possible redemption; 10,447,350 shares (at approximately $10.25 per share)	107,085,338
Stockholders' Deficit
Common stock	18
Class B common stock
Stockholders' Deficit
Common stock	$ 262

BALANCE SHEET (Parenthetical)

BALANCE SHEET (Parenthetical) - $ / shares	Dec. 31, 2020	Nov. 19, 2020
Preferred stock, par value	$ 0.0001
Preferred stock, shares authorized	1,000,000
Preferred stock, shares issued	0
Preferred stock, shares outstanding	0
Class A common stock
Shares subject to possible redemption	10,447,350	10.25
Shares subject to possible redemption, par value per share	$ 10.25
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	100,000,000
Common stock, shares issued	182,829
Common stock, shares outstanding	182,829
Temporary equity, par value	$ 10.25
Class B common stock
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	10,000,000
Common stock, shares issued	2,611,838
Common stock, shares outstanding	2,611,838

STATEMENT OF OPERATIONS

STATEMENT OF OPERATIONS	5 Months Ended
	Dec. 31, 2020USD ($)$ / sharesshares
Operating costs	$ 208,689
Loss from operations	(208,689)
Other income (expense):
Interest earned on cash and marketable securities held in Trust Account	9,155
Change in fair value of derivative warrant liabilities	(2,771,405)
Offering costs associated with warrants recorded as liabilities	309,851
Net loss	$ (3,280,790)
Class A common stock
Other income (expense):
Basic weighted average shares outstanding of common stock | shares	2,725,396
Diluted weighted average shares outstanding of common stock | shares	2,725,396
Basic net income / (loss) per share | $ / shares	$ (0.63)
Diluted net income / (loss) per share | $ / shares	$ (0.63)
Non-redeemable common stock
Other income (expense):
Basic weighted average shares outstanding of common stock | shares	2,481,084	[1]
Diluted weighted average shares outstanding of common stock | shares	2,481,084	[1]
Basic net income / (loss) per share | $ / shares	$ (0.63)
Diluted net income / (loss) per share | $ / shares	$ (0.63)
[1]	For the period from July 23, 2020 (inception) through December 31, 2020, the basic and diluted weighted average non-redeemable common stock outstanding consisted of 47,695 shares of Class A common stock and 2,611,838 shares of Class B common stock.

STATEMENT OF OPERATIONS (Parent

STATEMENT OF OPERATIONS (Parenthetical)	5 Months Ended
	Dec. 31, 2020shares
Class A common stock
Basic weighted average shares outstanding of common stock	2,725,396
Diluted weighted average shares outstanding of common stock	2,725,396
Non-redeemable class A common stock
Basic weighted average shares outstanding of common stock	47,695
Diluted weighted average shares outstanding of common stock	47,695
Non-redeemable class B common stock
Basic weighted average shares outstanding of common stock	2,611,838
Diluted weighted average shares outstanding of common stock	2,611,838

STATEMENT OF CHANGES IN STOCKHO

STATEMENT OF CHANGES IN STOCKHOLDERS' DEFICIT - 5 months ended Dec. 31, 2020 - USD ($)	Class A common stockCommon Stock	Class A common stock	Class B common stockCommon Stock	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at the beginning at Jul. 22, 2020	$ 0		$ 0	$ 0	$ 0	$ 0
Balance at the beginning (in shares) at Jul. 22, 2020	0		0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of Class B common stock to Sponsor		$ 107,100,000	$ 288	24,712		25,000
Issuance of Class B common stock to Sponsor (in shares)			2,875,000
Formation cost adjustment				2,179		2,179
Excess of cash received from private placement warrants				1,268,886		1,268,886
Forfeiture of Class B common stock			$ (26)	26
Forfeiture of Class B common stock (in shares)			(263,162)
Issuance of Representative Shares	$ 18			(18)
Issuance of Representative Shares (in shares)	182,829
Accretion for Class A common stock to redemption amount				$ (1,295,785)	(10,160,703)	(11,456,488)
Net loss					(3,280,790)	(3,280,790)
Balance at the end (in shares) at Dec. 31, 2020	182,829		2,611,838
Balance at the end at Dec. 31, 2020	$ 18		$ 262		$ (13,441,493)	$ (13,441,213)

STATEMENT OF CASH FLOWS

STATEMENT OF CASH FLOWS	5 Months Ended
	Dec. 31, 2020USD ($)
Cash Flows from Operating Activities:
Net loss	$ (3,280,790)
Adjustments to reconcile net loss to net cash used in operating activities:
Interest income earned on marketable securities held in Trust Account	(9,155)
Change in fair value of derivative warrant liabilities	2,771,405
Offering costs associated with warrants recorded as liabilities	309,851
Changes in operating assets and liabilities:
Prepaid expenses	(333,208)
Accrued expenses	155,524
Net cash used in operating activities	(386,373)
Cash Flows from Investing Activities:
Investment of cash and marketable securities in Trust Account	(107,085,338)
Net cash used in investing activities	(107,085,338)
Cash Flows from Financing Activities:
Proceeds from issuance of Class B common stock to Sponsor	25,000
Proceeds from sale of Units, net of underwriting discounts paid	103,169,760
Proceeds from sale of Private Placement Warrants	5,817,757
Proceeds from promissory note - related party	205,991
Repayment of promissory note - related party	(205,991)
Payment of offering costs	(549,086)
Net cash provided by financing activities	108,463,431
Net Change in Cash	991,720
Cash - Beginning of period	0
Cash - End of period	991,720
Non-cash investing and financing activities:
Deferred Underwriting Fee Payable	3,395,389
Initial Classification Of Derivative Warrant Liabilities	$ 8,452,978

ORGANIZATION AND DESCRIPTION OF

ORGANIZATION AND DESCRIPTION OF BUSINESS OPERATIONS	5 Months Ended
	Dec. 31, 2020
ORGANIZATION AND DESCRIPTION OF BUSINESS OPERATIONS
ORGANIZATION AND DESCRIPTION OF BUSINESS OPERATIONS	NOTE 1 – ORGANIZATION AND DESCRIPTION OF BUSINESS OPERATIONS OTR Acquisition Corp . (the “Company”) was incorporated in Delaware on July 23, 2020. The Company was formed for the purpose of entering into an initial merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses that the Company has not yet identified (the “Business Combination”). The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. The Company is not limited to a particular industry or sector for purposes of consummating a Business Combination, however, the Company intends to concentrate its efforts to initially focus on identifying businesses within North America. As of December 31, 2020, the Company had not commenced any operations. All activity for the period from July 23, 2020 (inception) through December 31, 2020 relates to the Company’s formation and the proposed initial public offering (“Initial Public Offering”), which is described below, and subsequent to the Initial Public Offering, identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company generates non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering. The Company’s sponsor is OTR Acquisition Sponsor LLC, a Delaware limited liability company (the “Sponsor”). The registration statement on Form S-1 for the Company’s Initial Public Offering was declared effective on November 17, 2020. On November 19, 2020, the Company consummated its Initial Public Offering of 10,000,000 units (the “Units” and, with respect to the Class A common stock included in the Units offered in the Initial Public Offering, the “Public Shares”) at $10.00 per Unit, generating gross proceeds of $100.0 million. The underwriters were granted a 45‑day option from the date of the final prospectus relating to the Initial Public Offering to purchase up to 1,500,000 additional Units to cover over-allotments, if any, at $10.00 per Unit. The underwriters’ over-allotment option was partially exercised, resulting in the purchase of an additional 447,350 Units, resulting into incremental gross proceeds of approximately $4.5 million. On December 21, 2020, the underwriters waived their right to exercise the remaining over-allotment option. Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement (“Private Placement”) of 5,650,000 warrants (each, a “Private Placement Warrant” and collectively, the “Private Placement Warrants”) to the Sponsor, each exercisable to purchase one share of Class A common stock at $11.50 per share, at a price of $1.00 per Private Placement Warrant, generating gross proceeds to the Company of $5.7 million. In connection with the partial exercise of the underwriters’ over-allotment option, the Sponsor purchased an additional 167,757 Private Placement Warrants at a price of $1.00 per Private Placement Warrant, generating additional gross proceeds of $0.17 million (Note 5). Transaction costs amounted to $7.1 million consisting of $1.8 million of the fair value of the shares issued to Maxim Group LLC for acting as the representative of the several underwriters in connection with the Initial Public Offering, $1.3 million in cash underwriting fees, $3.4 million of deferred underwriting fees and $0.55 million of other offering costs. In addition, as of December 31, 2020, cash of $0.99 million was held outside of the Trust Account (as defined below) and is available for the payment of offering costs and for working capital purposes. Upon the closing of the Initial Public Offering and the Private Placement, an amount of $107.1 million ($10.25 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the Private Placement was placed in a trust account (“Trust Account”) located in the United States at JP Morgan Chase Bank, N.A. with Continental Stock Transfer & Trust Company acting as trustee, and are invested only in U.S. government securities, within the meaning of Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a‑7 promulgated under the Investment Company Act, which invest only in direct U.S. government treasury obligations, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below. The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete a Business Combination with one or more operating businesses or assets that together have an aggregate fair market value equal to at least 80% of the net assets held in the Trust Account ( excluding the deferred underwriting commissions and taxes payable on the interest earned on the Trust Account ) at the time of the Company’s signing a definitive agreement in connection with a Business Combination. The Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires an interest in the target business or assets sufficient for it not to be required to register as an investment company under the Investment Company Act. The Company will provide its holders of the outstanding Public Shares (the “public stockholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve a Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company. The public stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.25 per Public Share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants. The Public Shares subject to redemption will be recorded at redemption value and classified as temporary equity upon the completion of the Initial Public Offering in accordance with the Financial Accounting Standards Board Accounting Standard Codification, or FASB ASC Topic 480, “Distinguishing Liabilities from Equity”. The Company will only proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 either prior to or upon such consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the shares voted are voted in favor of the Business Combination. If a stockholder vote is not required by applicable law or stock exchange rules and the Company does not decide to hold a stockholder vote for business or other reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation (the “Amended and Restated Certificate of Incorporation”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, stockholder approval of the transaction is required by applicable law or stock exchange rules, or the Company decides to obtain stockholder approval for business or other reasons, the Company will offer to redeem the Public Shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks stockholder approval in connection with a Business Combination, the Sponsor has agreed to vote its Founder Shares (as defined in Note 6), and any Public Shares purchased during or after the Initial Public Offering in favor of approving a Business Combination. Additionally, each public stockholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction or do not vote at all. Notwithstanding the above, if the Company seeks stockholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Amended Certificate of Incorporation provides that a public stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), will be restricted from redeeming its shares with respect to more than an aggregate of 20% or more of the Public Shares, without the prior consent of the Company. The Sponsor has agreed (a) to waive its redemption rights with respect to its Founder Shares and Public Shares held by it in connection with the completion of a Business Combination and (b) not to propose an amendment to the Certificate of Incorporation (i) to modify the substance or timing of the Company’s obligation to allow redemption in connection with the Company’s initial Business Combination or to redeem 100% of its Public Shares if the Company does not complete a Business Combination or (ii) with respect to any other provision relating to stockholders’ rights or pre-initial business combination activity, unless the Company provides the public stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment. The Company will have until 18 months from the closing of the Initial Public Offering, or May 19, 2022, to complete a Business Combination (the “Combination Period”). If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and the Company’s board of directors, dissolve and liquidate, subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless if the Company fails to complete a Business Combination within the Combination Period. The Sponsor has agreed to waive its liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Sponsor acquires Public Shares in or after the Initial Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 7) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than $10.25. In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below the lesser of (1) $10.25 per Public Share and (2) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the Trust Account nor will it apply to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except the Company’s independent registered public accounting firm), prospective target businesses and other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in, or to monies held in the Trust Account. Liquidity and Going Concern As of December 31, 2020, the Company had approximately $0.99 million in its operating bank account and working capital of approximately $1.2 million. Prior to the completion of the Initial Public Offering, the Company’s liquidity needs were satisfied through a payment of $25,000 from its Sponsor in exchange for the issuance of Founder Shares, as well as the loan under the Promissory Note of $0.21 million. Subsequent to the consummation of the Initial Public Offering on November 19, 2020, the Company’s liquidity needs had been satisfied with the net proceeds from the consummation of the Private Placement not held in the Trust Account. The Company fully repaid the Promissory Note on November 19, 2020. In addition, in order to finance transaction costs in connection with an initial Business Combination, Sponsor, an affiliate of the Sponsor, or certain of the Company’s officers and directors or their affiliates may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). To date, there were no amounts outstanding under any Working Capital Loan. The Company expects to incur significant costs in pursuit of its financing and acquisition plans. These conditions raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date that the accompanying financial statements are issued. Also, in connection with the Company’s assessment of going concern considerations in accordance with FASB ASC 205-40, “Basis of Presentation – Going Concern,” management has determined that mandatory liquidation and subsequent dissolution raise substantial doubt about the Company’s ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after May 19, 2022. The financial statements do not include any adjustment that might be necessary if the Company is unable to continue as a going concern. Management continues to evaluate the impact of the COVID-19 pandemic and has concluded that the specific impact is not readily determinable as of the date of these financial statements. The financial statement does not include any adjustments that might result from the outcome of this uncertainty.

RESTATEMENT OF PREVIOUSLY ISSUE

RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS	5 Months Ended
	Dec. 31, 2020
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS	NOTE 2 – RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS The Company concluded it should restate its previously issued financial statements by amending Amendment No. 1 to its Annual Report on Form 10-K/A, filed with the SEC on May 18, 2021, to classify all Class A common stock subject to possible redemption in temporary equity. In accordance with the SEC and its staff guidance on redeemable equity instruments in ASC 480-10-S99 paragraph 10-S99, redemption provisions not solely within the control of the Company require common stock subject to redemption to be classified outside of permanent equity. The Company had previously classified a portion of its Class A common stock in permanent equity. Although the Company did not specify a maximum redemption threshold, its charter currently provides that the Company will not redeem its Public Shares in an amount that would cause its net tangible assets to be less than $5,000,001. Previously, the Company did not consider redeemable stock classified as temporary equity as part of net tangible assets. Effective with these financial statements, the Company restated this interpretation to include temporary equity in net tangible assets. Also, in connection with the change in presentation for the Class A common stock subject to possible redemption, the Company also restated its earnings per share calculation to allocate income and losses shared pro rata between the two classes of shares including non-redeemable Class A common stocks together with Class B common stocks for EPS. This presentation contemplates a Business Combination as the most likely outcome, in which case, both classes of shares share pro rata in the income and losses of the Company. As a result, the Company restated its previously filed financial statements to present all redeemable Class A common stock as temporary equity and to recognize accretion from the initial book value to redemption value at the time of its Initial Public Offering and in accordance with ASC 480. The Company's previously filed financial statements that contained the error were initially reported in the Company's Form 8-K filed with the SEC on November 25, 2020 (the "IPO Balance Sheet") and the Company's Annual Report on 10-K for the annual period ended December 31, 2020, which were previously restated in the Company's Amendment No. 1 to its Form 10-K as filed with the SEC on May 18, 2021, as well as the Form 10-Qs for the quarterly periods ended March 31, 2021, June 30, 2021 and September 30, 2021 (the "Affected Periods"). These financial statements restate the Company's previously issued audited and unaudited financial statements covering the periods through December 31, 2020. The quarterly periods ended March 31, 2021, June 30, 2021 and September 30, 2021 will be restated in the Company's Form 10-Q/A for the quarterly period ended September 30, 2021. In connection with the change in presentation for the Class A common stock subject to redemption, the Company also restated its presentation Class A common stock and Class B common stock to present redeemable Class A and non-redeemable. As such, a portion of the Class A common stock is included in the weighted average shares outstanding non-redeemable common stock in the As Restated balances. This presentation contemplates a Business Combination as the most likely outcome, in which case, both classes of shares share pro rata in the income (loss) of the Company. Impact of the Restatement The impact of the restatement on the balance sheet as of November 19, 2020 is presented below. As Previously Reported in 8-K Adjustment As Restated Balance Sheet as of November 19, 2020 Class A common stock subject to possible redemption (at approximately $10.25 per share) $ 91,604,384 $ 15,480,954 $ 107,085,338 Stockholders’ equity (deficit) Class A common stock, $0.0001 par value 87 (69) 18 Class B common stock, $0.0001 par value 288 — 288 Additional paid-in capital 5,010,305 (5,010,305) — Accumulated deficit (10,679) (10,470,580) (10,481,259) Total stockholders’ equity (deficit) $ 5,000,001 $ (15,480,954) $ (10,480,953) The impact of the restatement on the audited balance sheet as of December 31, 2020 is presented below: As Reported As Previously Restated in 10-K/A Amendment No. 1 Adjustment As Restated Balance Sheet as of December 31, 2020 Class A common stock subject to possible redemption (at approximately $10.25 per share) $ 88,644,124 $ 18,441,214 $ 107,085,338 Stockholders’ equity (deficit) Class A common stock, $0.0001 par value 198 (180) 18 Class B common stock, $0.0001 par value 262 — 262 Additional paid-in capital 8,280,331 (8,280,331) — Accumulated deficit (3,280,790) (10,160,703) (13,441,493) Total stockholders’ equity (deficit) $ 5,000,001 $ (18,441,214) $ (13,441,213) The impact to the reported amounts of weighted average shares outstanding and basic and diluted earnings per share of common stock is presented below for the period ended December 31, 2020: As Reported As Previously Restated in 10-K/A Amendment No. 1 Adjustment As Restated Statement of Operations for the period from July 23, 2020 (inception) through December 31, 2020 Net loss $ (3,280,790) $ — $ (3,280,790) Basic and diluted weighted average shares outstanding of Class A common stock 10,630,179 (10,630,179) — Basic and diluted net loss per share, Class A common stock $ 0.00 $ (0.00) $ — Basic and diluted, weighted average shares outstanding of Class B common stock 2,531,315 (2,531,315) — Basic and diluted net loss per share, Class B common stock $ (1.30) $ 1.30 $ — Weighted average shares outstanding, redeemable common stock — 2,725,396 2,725,396 Basic and diluted net loss per share, redeemable common stock $ — $ (0.63) $ (0.63) Weighted average shares outstanding, non-redeemable common stock — 2,481,084 2,481,084 Basic and diluted net loss per share, non-redeemable common stock $ — $ (0.63) $ (0.63) The impact of the restatement to the previously reported as restated statement of cash flows for the period ended December 31, 2020, is presented below: As Reported As Previously Restated in 10-K/A Amendment No. 1 Adjustment As Restated Statement of Cash Flows for the period from July 23, 2020 (inception) through December 31, 2020 Supplemental Disclosure of Non-Cash Financing Activities: Initial classification of common stock subject to possible redemption $ 100,057,362 $ (100,057,362) — Change in value of common stock subject to possible redemption $ (11,413,238) $ 11,413,238 —

SIGNIFICANT ACCOUNTING POLICIES

SIGNIFICANT ACCOUNTING POLICIES	5 Months Ended
	Dec. 31, 2020
SIGNIFICANT ACCOUNTING POLICIES
SIGNIFICANT ACCOUNTING POLICIES	NOTE 3 – Basis of Presentation The accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the SEC. As described in the Company's Form 8-K filed on November 30, 2021 and in Note 2-Restatement of Previously Issued Financial Statements, the Company's financial statements as of and for the period from July 23, 2020 (inception) through December 31, 2020, and the IPO Balance Sheet as of November 19, 2020 (collectively, the "Affected Periods"), are restated in this Annual Report on Form 10-K/A (Amendment No. 2) (this "Annual Report") to correct the misapplication of accounting guidance related to the Company's Public Shares in the Company's previously issued audited and unaudited condensed financial statements for such periods. The restated financial statements are indicated as "Restated" in the audited and accompanying notes, as applicable. See Note 2-Restatement of Previously Issued Financial Statements for further discussion. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of Estimates The preparation of financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of December 31, 2020. Marketable Securities Held in Trust Account At December 31, 2020, substantially all of the assets held in the Trust Account were held in U.S. Treasury Bills. Common Stock Subject to Possible Redemption All of the 10,447,350 shares of Class A common stock sold as part of the Units in the Initial Public Offering contain a redemption feature. In accordance with the Accounting Standards Codification 480-10-S99-3A, “Classification and Measurement of Redeemable Securities”, redemption provisions not solely within the control of the Company require the security to be classified outside of permanent equity. Ordinary liquidation events, which involve the redemption and liquidation of all of the entity’s equity instruments, are excluded from the provisions of ASC 480. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount value. The change in the carrying value of redeemable shares of Class A common stock resulted in charges against additional paid-in capital (to the extent available) and accumulated deficit. As of December 31, 2020, the shares of Class A common stock reflected on the balance sheet are reconciled in the following table: Gross proceeds $ Less: Proceeds allocated to public warrants (3,904,107) Class A shares issuance costs (4,940,543) Plus: Accretion of carrying value to redemption value 11,456,488 Class A common stock subject to possible redemption $ 107,085,338 Offering Costs Offering costs consist of legal, accounting, underwriting fees, and other costs incurred that were directly related to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with derivative warrant liabilities are expenses as incurred, presented as non-operating expenses in the statement of operations. Offering costs associated with the Public Shares were charged to stockholders’ equity upon the completion of the Initial Public Offering. Of the total offering costs of the Initial Public Offering, approximately $0.31 million is included in the offering costs associated with warrants recorded as liabilities in the statement of operations and approximately $8.5 million is included in the stockholders’ equity. Net Loss Per Share of Common Stock The Company applies the two-class method in calculating earnings per share. The contractual formula utilized to calculate the redemption amount approximates fair value. The Class feature to redeem at fair value means that there is effectively only one class of stock. Changes in fair value are not considered a dividend of the purposes of the numerator in the earnings per share calculation. Net loss per common stock is computed by dividing the pro rata net loss between the Class A common stock and the Class B common stock by the weighted average number of common stock outstanding for each of the periods. The calculation of diluted loss per common stock does not consider the effect of the warrants issued in connection with the Initial Public Offering since the exercise of the warrants is contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive. The warrants are exercisable for 11,041,432 shares of Class A common stock in the aggregate. For the period from July 23, 2020 (inception) through December 31, 2020 Redeemable Shares Non-Redeemable Shares Basic and diluted net loss per share: Numerator: Allocation of net loss $ (1,717,370) $ (1,563,420) Denominator: Weighted-average shares outstanding 2,725,396 2,481,084 Basic and diluted net loss per share $ (0.63) $ (0.63) Concentration of Credit Risk Financial instruments that potentially subject the Company to concentration of credit risk consist of cash accounts in a financial institution which, at times, may exceed the federal depository insurance corporation limit of $250,000. At December 31, 2020, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. Fair Value of Financial Instruments Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: · Level 1 - Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. · Level 2 - Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. · Level 3 - Unobservable inputs based on the Company’s assessment of the assumptions that market participants would use in pricing the asset or liability. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. As of December 31, 2020, the carrying values of cash and accrued expenses approximate their fair values due to the short-term nature of the instruments. The Company’s marketable securities held in Trust Account are comprised of investments in U.S. Treasury securities with an original maturity of 185 days. The fair value of marketable securities held in Trust Account is determined using quoted prices in active markets. Derivative Warrant Liabilities The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and ASC 815-15. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. The 5,223,675 Public Warrants (defined in Note 4) and the 5,817,757 Private Placement Warrants are recognized as derivative liabilities in accordance with ASC 815-40. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjust the instruments to fair value at each reporting period. The liabilities are subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s statement of operations. The fair value of the Public Warrants issued in connection with the Initial Public Offering and Private Placement Warrants were initially measured at fair value using a Monte Carlo simulation model and subsequently, the fair value of the Private Placement Warrants have been estimated using a Monte Carlo simulation model each measurement date. The fair value of Public Warrants issued in connection with the Initial Public Offering have subsequently been measured based on the listed market price of such warrants. Income Taxes The Company complies with the accounting and reporting requirements of FASB ASC 740, “Income Taxes,” which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. There were no unrecognized tax benefits as of December 31, 2020. FASB ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties at December 31, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals, or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. Recent Accounting Standards Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statements.

INITIAL PUBLIC OFFERING

INITIAL PUBLIC OFFERING	5 Months Ended
	Dec. 31, 2020
INITIAL PUBLIC OFFERING
INITIAL PUBLIC OFFERING	NOTE 4 – INITIAL PUBLIC OFFERING Pursuant to the Initial Public Offering, the Company sold 10,447,350 Units, which includes the partial exercise by the underwriters of their over-allotment option in the amount of 447,350 Units, at a purchase price of $10.00 per Unit, generating gross proceeds of $104.5 million. Each Unit consists of one share of Class A common stock and one-half warrant (“Public Warrant”). Each whole Public Warrant entitles the holder to purchase one share of the Company’s Class A common stock at an exercise price of $11.50 per share (see Note 8).

PRIVATE PLACEMENT WARRANTS

PRIVATE PLACEMENT WARRANTS	5 Months Ended
	Dec. 31, 2020
PRIVATE PLACEMENT WARRANTS
PRIVATE PLACEMENT WARRANTS	NOTE 5 – PRIVATE PLACEMENT WARRANTS Simultaneously with the closing of the Initial Public Offering, the Company consummated the Private Placement of 5,817,757 Private Placement Warrants, including 167,757 Private Placement Warrants purchased in connection with the underwriters' partial over-allotment option ( each exercisable to purchase one share of Class A common stock at $11.50 per share) at a price of $1.00 per Private Placement Warrant, generating gross proceeds to us of $5.8 million. The proceeds from the Private Placement Warrants were added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Warrants held in the Trust Account will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Placement Warrants will expire worthless.

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	5 Months Ended
	Dec. 31, 2020
RELATED PARTY TRANSACTIONS
RELATED PARTY TRANSACTIONS	NOTE 6 – RELATED PARTY TRANSACTIONS Founder Shares On August 3, 2020, the Sponsor purchased 7,187,500 shares of the Company’s Class B common stock (the “Founder Shares”) for an aggregate purchase price of $25,000. On October 25, 2020, the Sponsor effected a surrender of 3,881,250 shares of Class B common stock to the Company for no consideration, resulting in a decrease in the total number of shares of Class B common stock outstanding from 7,187,500 to 3,306,250. A further surrender of 431,250 shares of Class B common stock was effected on November 17, 2020 by the Sponsor to the Company for no consideration, resulting in a decrease in the total number of shares of Class B common stock outstanding from 3,306,250 to 2,875,000. All shares and associated amounts have been retroactively restated to reflect the share capitalization. The Founder Shares included an aggregate of up to 375,000 Class B common stock subject to forfeiture by the Sponsor to the extent that the underwriters’ over-allotment was not exercised in full or in part, so that the number of Founder Shares would collectively represent 20% of the Company’s issued and outstanding shares upon the completion of the Initial Public Offering. On November 19, 2020, the underwriters partially exercised their over-allotment option. On December 21, 2020, the underwriters waived their right to exercise the remaining over-allotment option and the forfeiture of 263,162 Founder Shares. Forfeiture of 263,162 Founder Shares resulted in an aggregate of 2,611,838 Founders Shares issued and outstanding, so that the number of shares of Class B common stock collectively equaled 20% of the Company’s issued and outstanding common stock after the Initial Public Offering. Founder Shares are subject to lock-up until the earlier of (A) one year after the completion of the Company’s Business Combination or (B) the date on which the Company completes a liquidation, merger, stock exchange or other similar transaction after the Company’s Business Combination that results in all of the Company’s public stockholders having the right to exchange their shares of common stock for cash, securities or other property. Notwithstanding the foregoing, if the last sale price of the Company’s common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30‑trading day period 150 days after an initial Business Combination, the Founder Shares will be released. Promissory Note – Related Party On July 23, 2020, the Sponsor issued an unsecured promissory note to the Company (the “Promissory Note”), pursuant to which the Company could have borrowed up to an aggregate principal amount of $300,000. The Promissory Note was non-interest bearing and was payable on the earlier of December 31, 2020 or the consummation of the Initial Public Offering. The total outstanding balance of $205,991 was paid in full on November 19, 2020. Related Party Loans In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor, an affiliate of the Sponsor, or certain of the Company’s officers and directors or their affiliates may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $2.5 million of such Working Capital Loans may be convertible into warrants of the post Business Combination entity. The warrants would be identical to the Private Placement Warrants. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. As of December 31, 2020, no Working Capital Loans were outstanding. Administrative Support Agreement Commencing on the effective date of the Initial Public Offering, the Company pays the Sponsor a total of up to $10,000 per month in the aggregate for up to 18 months for office space, utilities and secretarial and administrative support. Upon completion of the Initial Business Combination or the Company’s liquidation, the Company will cease paying these monthly fees. For the period ended December 31, 2020, the Company incurred $20,000 for these services, of which such amount is included in the operating costs on accompanying statement of operations.

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	5 Months Ended
	Dec. 31, 2020
COMMITMENTS AND CONTINGENCIES
COMMITMENTS AND CONTINGENCIES	NOTE 7 – COMMITMENTS AND CONTINGENCIES Risks and Uncertainties Management continues to evaluate the impact of the COVID‑19 pandemic on the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. Registration Rights The holders of the Founder Shares, Private Placement Warrants, and warrants that may be issued upon conversion of Working Capital Loans (and any shares of common stock issuable upon the exercise of the Private Placement Warrants or warrants issued upon conversion of the Working Capital Loans and upon conversion of the Founder Shares) will be entitled to registration rights pursuant to a registration rights agreement dated as of November 17, 2020, which requires the Company to register such securities for resale (in the case of the Founder Shares, only after conversion to shares of Class A common stock). Pursuant to such registration rights agreement, the holders of these securities will be entitled to make up to three demands, excluding short form registration demands, that the Company register such securities. In addition, the holders will have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of an initial Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The Company granted the underwriters a 45-day option from the date of Initial Public Offering to purchase up to 1,500,000 additional Units to cover over-allotments, if any, at the Initial Public Offering price less the underwriting discounts and commissions. The underwriters partially exercised the over-allotment option on November 17, 2020. The underwriters waived their right to exercise the remaining over-allotment option on December 21, 2020. The underwriters were paid an underwriting discount of $0.125 per unit, or $1.3 million in the aggregate. In addition, the underwriters are entitled to a deferred fee of $0.325 per unit, or $3.4 million in the aggregate which will be payable to the underwriters for deferred underwriting commissions. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement entered into in connection with the Initial Public Offering. Representative’s Common Stock The Company issued to the underwriters from the Initial Public Offering, 182,829 shares of Class A common stock upon the consummation of the Initial Public Offering. The underwriters agreed not to transfer, assign or sell any such shares until the completion of the Company’s initial Business Combination. In addition, the underwriters have agreed (i) to waive its redemption rights with respect to such shares in connection with the completion of a Business Combination and (ii) to waive its rights to liquidating distributions from the Trust Account with respect to such shares if the Company fails to complete a Business Combination within 18 months from the closing of the Initial Public Offering. Based on the Initial Public Offering price of $10.00 per Unit, the fair value of the 182,829 shares of Class A common stock was $1.8 million, which was an expense of the Initial Public Offering, resulting in a charge directly to stockholders’ equity upon the completion of the Initial Public Offering. The shares received by the underwriters described immediately above have been deemed compensation by FINRA and are therefore subject to a lock-up for a period of 180 days immediately following the date of the effectiveness of the registration statement on Form S-1 filed with the SEC in connection with the Initial Public Offering (the “Registration Statement”) pursuant to Rule 5110(g)(1) of FINRA’s NASD Conduct Rules. Pursuant to FINRA Rule 5110(g)(1), these securities will not be the subject of any hedging, short sale, derivative, put or call transaction that would result in the economic disposition of the securities by any person for a period of 180 days immediately following the effective date of the Registration Statement, nor may they be sold, transferred, assigned, pledged or hypothecated for a period of 180 days immediately following the effective date of the Registration Statement of except to any underwriter and selected dealer participating in the offering and their bona fide officers or partners.

STOCKHOLDERS' DEFICIT

STOCKHOLDERS' DEFICIT	5 Months Ended
	Dec. 31, 2020
STOCKHOLDERS' DEFICIT
STOCKHOLDERS' DEFICIT	NOTE 8 – STOCKHOLDERS’ DEFICIT Common Stock Preferred Stock - The Company is authorized to issue 1,000,000 preferred shares with a par value of $0.0001 per preferred share. As of December 31, 2020, there are no preferred shares issued or outstanding. Class A Common Stock - The Company is authorized to issue 100,000,000 shares of Class A common stock with a par value of $0.0001 per share. As of December 31, 2020, there were 182,829 shares of Class A common stock issued or outstanding, which are non-redeemable. This number excludes 10,447,350 shares of Class A common stock that are subject to possible amounting to $107.1 million, that were issued as part of the Units sold at the Initial Public Offering. Class B Common Stock - The Company is authorized to issue 10,000,000 shares of Class B common stock, with a par value of $0.0001 per share. Holders of the Class B common stock are entitled to one vote for each share. At December 31, 2020 there were 2,611,838 shares of Class B common stock issued and outstanding. Holders of Class A common stock and holders of Class B common stock, voting together as a single class, for the election of directors on all other matters submitted to a vote of the Company’s stockholders except as otherwise required by law. The shares of Class B common stock will automatically convert into shares of Class A common stock at the time of a Business Combination on a one-for-one basis, subject to adjustment. In the case that additional shares of Class A common stock, or equity-linked securities, are issued or deemed issued in excess of the amounts offered in the closing of a Business Combination, the ratio at which shares of Class B common stock shall convert into shares of Class A common stock will be adjusted (unless the holders of a majority of the outstanding shares of Class B common stock agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of shares of Class A common stock issuable upon conversion of all shares of Class B common stock will equal, in the aggregate, on an as-converted basis, 20% of the sum of the total number of all shares of common stock outstanding upon the completion of the Initial Public Offering (not including the shares of Class A common stock underlying the Placement Units) plus all shares of Class A common stock and equity-linked securities issued or deemed issued in connection with a Business Combination. In addition, the calculation mentioned above will be subject to adjustment for stock splits, stock dividends, reorganizations, recapitalizations, and the like. In no event will the Class B common stock convert into Class A common stock at a rate of less than one to one.

DERIVATIVE WARRANT LIABILITIES

DERIVATIVE WARRANT LIABILITIES	5 Months Ended
	Dec. 31, 2020
DERIVATIVE WARRANT LIABILITIES
DERIVATIVE WARRANT LIABILITIES	NOTE 9 – DERIVATIVE WARRANT LIABILITIES As of December 31, 2020, the Company has 5,223,675 and 5,817,757 Public Warrants and Private Placement Warrants, respectively, outstanding. Public Warrants Public Warrants may only be exercised for a whole number of shares. No fractional shares will be issued upon exercise of the Public Warrants. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination and (b) 12 months from the closing of the Initial Public Offering. Redemption of Warrants When the Price per Share of Class A Common Stock Equals or Exceeds $18.00 —once the warrants become exercisable, the Company may redeem the outstanding Public Warrants: · in whole and not in part; · at a price of $0.01 per Public Warrant; · upon not less than 30 days’ prior written notice of redemption to each warrant holder; and · if, and only if, the last reported sale price of the Class A common stock for any 20 trading days within a 30-trading day period ending three business days before sending the notice of redemption to warrant holders (the “Reference Value”) equals or exceeds $18.00 per share (as adjusted for stock splits, stock capitalizations, reorganizations, recapitalizations and the like). In addition, if (x) the Company issues additional shares of common stock or equity- linked securities for capital raising purposes in connection with the closing of our initial business combination at an issue price or effective issue price of less than $9.20 per share (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to our Sponsor or its affiliates, without taking into account any Founder Shares held by our Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the Company’s initial business combination on the date of the consummation of the Company’s initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s Class A common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its initial business combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price described above in this section will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price. Private Placement Warrants The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that (x) the Private Placement Warrants and the Class A common stock issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions, (y) the Private Placement Warrants will be exercisable on a cashless basis and be non-redeemable so long as they are held by the initial purchasers or their permitted transferees and (z) the Private Placement Warrants and the Class A common stock issuable upon exercise of the Private Placement Warrants will be entitled to registration rights. If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.

INCOME TAX

INCOME TAX	5 Months Ended
	Dec. 31, 2020
INCOME TAX
INCOME TAX	NOTE 10 – INCOME TAX The income tax provision consists of the following: December 31, 2020 Federal Deferred 40,502 State Deferred 6,666 Change in valuation allowance (47,168) Income tax provision $ — The Company’s net deferred tax assets are as follows: December 31, 2020 Deferred tax asset 47,168 Valuation allowance (47,168) Deferred tax asset, net of allowance $ — As of December 31, 2020, the Company has a $79,419 U.S. federal and state net operating loss carryover available to offset future taxable income. In assessing the realization of the deferred tax assets, management considers whether it is more likely than not that some portion of all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which temporary differences representing net future deductible amounts become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment. After consideration of all of the information available, management believes that significant uncertainty exists with respect to future realization of the deferred tax assets and has therefore established a full valuation allowance. For the period ended December 31, 2020, the change in the valuation allowance was $47,168. A reconciliation of the federal income tax rate to the Company’s effective tax rate for the period ended December 31, 2020 is as follows: Statutory federal income tax rate 21.00 % State taxes, net of federal tax benefit 3.52 % Change in fair value of the derivative warrant liabilities (17.70) % Offering costs (2.00) % Change in valuation allowance (4.82) % Income tax provision benefit % The Company files income tax returns in the U.S. federal jurisdiction and various state and local jurisdictions and is subject to examination by the various taxing authorities.

FAIR VALUE MEASUREMENTS

FAIR VALUE MEASUREMENTS	5 Months Ended
	Dec. 31, 2020
FAIR VALUE MEASUREMENTS
FAIR VALUE MEASUREMENTS	NOTE 11 – FAIR VALUE MEASUREMENTS The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities: · Level 1 - Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. · Level 2 - Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. · Level 3 - Unobservable inputs based on the Company’s assessment of the assumptions that market participants would use in pricing the asset or liability. The fair value of the Public Warrants and Private Placement Warrants were initially measured at fair value using a Monte Carlo simulation model and subsequently, the fair value of the Private Placement Warrants have been estimated using a Monte Carlo simulation model each measurement date. The fair value of Public Warrants issued in connection with the Initial Public Offering have been measured based on the listed market price of such warrants since November 2020. For the period ended December 31, 2020, the Company recognized a charge to the statement of operations resulting from decrease in the fair value of liabilities of $2.8 million presented as change in fair value of derivative warrant liabilities in the accompanying statement of operations. The following table presents information about the Company’s financial assets that are measured at fair value on a recurring basis as of December 31, 2020 by level within the fair value hierarchy: Significant Significant Quoted Prices Other Other in Active Observable Unobservable Markets Inputs Inputs Description (Level 1) (Level 2) (Level 3) Assets: U.S. Treasury securities $ 106,966,830 $ — $ — $ 106,966,830 $ — $ — Liabilities: Derivative warrant liabilities - Public $ — $ — $ 5,284,490 Derivative warrant liabilities - Private — — 5,939,893 $ — $ — $ 11,224,383 As of December 31, 2020, there was $127,663 of cash held in the trust account. Transfers to/from Levels 1, 2 and 3 are recognized at the end of the reporting period. There were no transfers between Levels 1, 2 or 3 during the period ended December 31, 2020. The estimated fair value of the Private Placement Warrants, and the Public Warrants prior to being separately listed and traded, is determined using Level 3 inputs. Inherent in a Monte Carlo simulation are assumptions related to expected stock-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its common stock warrants based on implied volatility from the Company’s traded warrants and from historical volatility of select peer company’s common stock that matches the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates remaining at zero. The following table provides quantitative information regarding Level 3 fair value measurements inputs as their measurement dates: As of December 31, 2020 Initial Measurement Exercise Price $ 11.50 $ 11.50 Stock Price 10.30 9.63 Volatility 15.1 % 15.2 % Probability of completing a Business Combination 88.3 % 88.3 % Term (in years) 5.88 6.00 Risk-free rate 0.49 % 0.51 % The change in the fair value of the derivative warrant liabilities for the period ended December 31, 2020 is summarized as follows: Private Placement Public Placement Total Derivative Warrants Warrants Warrant Liabilities Initial measurement on November 19, 2020 $ 4,548,871 $ 3,904,107 $ 8,452,978 Change in fair value of derivative warrant liabilities 1,391,022 1,380,383 2,771,405 Derivative warrant liabilities at December 31, 2020 $ 5,939,893 $ 5,284,490 $ 11,224,383

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	5 Months Ended
	Dec. 31, 2020
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS	NOTE 12 – SUBSEQUENT EVENTS The Company evaluated subsequent events and transactions in Note 2 (Restatement of Previously Issued Financial Statements) that occurred after the balance sheet date up to the date financial statements were issued. Other than as described herein, the Company did not identify any other subsequent events that would have required adjustment or disclosure in the financial statements.

SIGNIFICANT ACCOUNTING POLICI_2

SIGNIFICANT ACCOUNTING POLICIES (Policies)	5 Months Ended
	Dec. 31, 2020
SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation	Basis of Presentation The accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the SEC. As described in the Company's Form 8-K filed on November 30, 2021 and in Note 2-Restatement of Previously Issued Financial Statements, the Company's financial statements as of and for the period from July 23, 2020 (inception) through December 31, 2020, and the IPO Balance Sheet as of November 19, 2020 (collectively, the "Affected Periods"), are restated in this Annual Report on Form 10-K/A (Amendment No. 2) (this "Annual Report") to correct the misapplication of accounting guidance related to the Company's Public Shares in the Company's previously issued audited and unaudited condensed financial statements for such periods. The restated financial statements are indicated as "Restated" in the audited and accompanying notes, as applicable. See Note 2-Restatement of Previously Issued Financial Statements for further discussion.
Emerging Growth Company	Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ from those estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of December 31, 2020.
Marketable Securities Held in Trust Account	Marketable Securities Held in Trust Account At December 31, 2020, substantially all of the assets held in the Trust Account were held in U.S. Treasury Bills.
Common Stock Subject to Possible Redemption	Common Stock Subject to Possible Redemption All of the 10,447,350 shares of Class A common stock sold as part of the Units in the Initial Public Offering contain a redemption feature. In accordance with the Accounting Standards Codification 480-10-S99-3A, “Classification and Measurement of Redeemable Securities”, redemption provisions not solely within the control of the Company require the security to be classified outside of permanent equity. Ordinary liquidation events, which involve the redemption and liquidation of all of the entity’s equity instruments, are excluded from the provisions of ASC 480. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount value. The change in the carrying value of redeemable shares of Class A common stock resulted in charges against additional paid-in capital (to the extent available) and accumulated deficit. As of December 31, 2020, the shares of Class A common stock reflected on the balance sheet are reconciled in the following table: Gross proceeds $ Less: Proceeds allocated to public warrants (3,904,107) Class A shares issuance costs (4,940,543) Plus: Accretion of carrying value to redemption value 11,456,488 Class A common stock subject to possible redemption $ 107,085,338
Offering Costs	Offering Costs Offering costs consist of legal, accounting, underwriting fees, and other costs incurred that were directly related to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with derivative warrant liabilities are expenses as incurred, presented as non-operating expenses in the statement of operations. Offering costs associated with the Public Shares were charged to stockholders’ equity upon the completion of the Initial Public Offering. Of the total offering costs of the Initial Public Offering, approximately $0.31 million is included in the offering costs associated with warrants recorded as liabilities in the statement of operations and approximately $8.5 million is included in the stockholders’ equity.
Net Loss Per Share of Common Stock	Net Loss Per Share of Common Stock The Company applies the two-class method in calculating earnings per share. The contractual formula utilized to calculate the redemption amount approximates fair value. The Class feature to redeem at fair value means that there is effectively only one class of stock. Changes in fair value are not considered a dividend of the purposes of the numerator in the earnings per share calculation. Net loss per common stock is computed by dividing the pro rata net loss between the Class A common stock and the Class B common stock by the weighted average number of common stock outstanding for each of the periods. The calculation of diluted loss per common stock does not consider the effect of the warrants issued in connection with the Initial Public Offering since the exercise of the warrants is contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive. The warrants are exercisable for 11,041,432 shares of Class A common stock in the aggregate. For the period from July 23, 2020 (inception) through December 31, 2020 Redeemable Shares Non-Redeemable Shares Basic and diluted net loss per share: Numerator: Allocation of net loss $ (1,717,370) $ (1,563,420) Denominator: Weighted-average shares outstanding 2,725,396 2,481,084 Basic and diluted net loss per share $ (0.63) $ (0.63)
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentration of credit risk consist of cash accounts in a financial institution which, at times, may exceed the federal depository insurance corporation limit of $250,000. At December 31, 2020, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.
Fair Value of Financial Instruments	Fair Value of Financial Instruments Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: · Level 1 - Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. · Level 2 - Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. · Level 3 - Unobservable inputs based on the Company’s assessment of the assumptions that market participants would use in pricing the asset or liability. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. As of December 31, 2020, the carrying values of cash and accrued expenses approximate their fair values due to the short-term nature of the instruments. The Company’s marketable securities held in Trust Account are comprised of investments in U.S. Treasury securities with an original maturity of 185 days. The fair value of marketable securities held in Trust Account is determined using quoted prices in active markets.
Derivative Warrant Liabilities	Derivative Warrant Liabilities The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and ASC 815-15. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. The 5,223,675 Public Warrants (defined in Note 4) and the 5,817,757 Private Placement Warrants are recognized as derivative liabilities in accordance with ASC 815-40. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjust the instruments to fair value at each reporting period. The liabilities are subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s statement of operations. The fair value of the Public Warrants issued in connection with the Initial Public Offering and Private Placement Warrants were initially measured at fair value using a Monte Carlo simulation model and subsequently, the fair value of the Private Placement Warrants have been estimated using a Monte Carlo simulation model each measurement date. The fair value of Public Warrants issued in connection with the Initial Public Offering have subsequently been measured based on the listed market price of such warrants.
Income Taxes	Income Taxes The Company complies with the accounting and reporting requirements of FASB ASC 740, “Income Taxes,” which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. There were no unrecognized tax benefits as of December 31, 2020. FASB ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties at December 31, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals, or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.
Recent Accounting Standards	Recent Accounting Standards Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statements.

RESTATEMENT OF PREVIOUSLY ISS_2

RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Tables)	5 Months Ended
	Dec. 31, 2020
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS
Summary of changes to the previously issued financial information	As Previously Reported in 8-K Adjustment As Restated Balance Sheet as of November 19, 2020 Class A common stock subject to possible redemption (at approximately $10.25 per share) $ 91,604,384 $ 15,480,954 $ 107,085,338 Stockholders’ equity (deficit) Class A common stock, $0.0001 par value 87 (69) 18 Class B common stock, $0.0001 par value 288 — 288 Additional paid-in capital 5,010,305 (5,010,305) — Accumulated deficit (10,679) (10,470,580) (10,481,259) Total stockholders’ equity (deficit) $ 5,000,001 $ (15,480,954) $ (10,480,953) As Reported As Previously Restated in 10-K/A Amendment No. 1 Adjustment As Restated Balance Sheet as of December 31, 2020 Class A common stock subject to possible redemption (at approximately $10.25 per share) $ 88,644,124 $ 18,441,214 $ 107,085,338 Stockholders’ equity (deficit) Class A common stock, $0.0001 par value 198 (180) 18 Class B common stock, $0.0001 par value 262 — 262 Additional paid-in capital 8,280,331 (8,280,331) — Accumulated deficit (3,280,790) (10,160,703) (13,441,493) Total stockholders’ equity (deficit) $ 5,000,001 $ (18,441,214) $ (13,441,213) As Reported As Previously Restated in 10-K/A Amendment No. 1 Adjustment As Restated Statement of Operations for the period from July 23, 2020 (inception) through December 31, 2020 Net loss $ (3,280,790) $ — $ (3,280,790) Basic and diluted weighted average shares outstanding of Class A common stock 10,630,179 (10,630,179) — Basic and diluted net loss per share, Class A common stock $ 0.00 $ (0.00) $ — Basic and diluted, weighted average shares outstanding of Class B common stock 2,531,315 (2,531,315) — Basic and diluted net loss per share, Class B common stock $ (1.30) $ 1.30 $ — Weighted average shares outstanding, redeemable common stock — 2,725,396 2,725,396 Basic and diluted net loss per share, redeemable common stock $ — $ (0.63) $ (0.63) Weighted average shares outstanding, non-redeemable common stock — 2,481,084 2,481,084 Basic and diluted net loss per share, non-redeemable common stock $ — $ (0.63) $ (0.63) As Reported As Previously Restated in 10-K/A Amendment No. 1 Adjustment As Restated Statement of Cash Flows for the period from July 23, 2020 (inception) through December 31, 2020 Supplemental Disclosure of Non-Cash Financing Activities: Initial classification of common stock subject to possible redemption $ 100,057,362 $ (100,057,362) — Change in value of common stock subject to possible redemption $ (11,413,238) $ 11,413,238 —

SIGNIFICANT ACCOUNTING POLICI_3

SIGNIFICANT ACCOUNTING POLICIES (Tables)	5 Months Ended
	Dec. 31, 2020
SIGNIFICANT ACCOUNTING POLICIES
Summary of reconciliation of Class A common stock reflected on the balance sheet	Gross proceeds $ Less: Proceeds allocated to public warrants (3,904,107) Class A shares issuance costs (4,940,543) Plus: Accretion of carrying value to redemption value 11,456,488 Class A common stock subject to possible redemption $ 107,085,338
Schedule of net income per share of common stock	For the period from July 23, 2020 (inception) through December 31, 2020 Redeemable Shares Non-Redeemable Shares Basic and diluted net loss per share: Numerator: Allocation of net loss $ (1,717,370) $ (1,563,420) Denominator: Weighted-average shares outstanding 2,725,396 2,481,084 Basic and diluted net loss per share $ (0.63) $ (0.63)

INCOME TAX (Tables)

INCOME TAX (Tables)	5 Months Ended
	Dec. 31, 2020
INCOME TAX
Schedule of income tax provision	The income tax provision consists of the following: December 31, 2020 Federal Deferred 40,502 State Deferred 6,666 Change in valuation allowance (47,168) Income tax provision $ —
Schedule of Company's net deferred tax assets	The Company’s net deferred tax assets are as follows: December 31, 2020 Deferred tax asset 47,168 Valuation allowance (47,168) Deferred tax asset, net of allowance $ —
Schedule of reconciliation of the federal income tax rate to the Company's effective tax rate	A reconciliation of the federal income tax rate to the Company’s effective tax rate for the period ended December 31, 2020 is as follows: Statutory federal income tax rate 21.00 % State taxes, net of federal tax benefit 3.52 % Change in fair value of the derivative warrant liabilities (17.70) % Offering costs (2.00) % Change in valuation allowance (4.82) % Income tax provision benefit %

FAIR VALUE MEASUREMENTS (Tables

FAIR VALUE MEASUREMENTS (Tables)	5 Months Ended
	Dec. 31, 2020
FAIR VALUE MEASUREMENTS
Schedule of financial assets that are measured at fair value on a recurring basis	The following table presents information about the Company’s financial assets that are measured at fair value on a recurring basis as of December 31, 2020 by level within the fair value hierarchy: Significant Significant Quoted Prices Other Other in Active Observable Unobservable Markets Inputs Inputs Description (Level 1) (Level 2) (Level 3) Assets: U.S. Treasury securities $ 106,966,830 $ — $ — $ 106,966,830 $ — $ — Liabilities: Derivative warrant liabilities - Public $ — $ — $ 5,284,490 Derivative warrant liabilities - Private — — 5,939,893 $ — $ — $ 11,224,383
Schedule of quantitative information regarding Level 3 fair value measurements inputs as their measurement dates	The following table provides quantitative information regarding Level 3 fair value measurements inputs as their measurement dates: As of December 31, 2020 Initial Measurement Exercise Price $ 11.50 $ 11.50 Stock Price 10.30 9.63 Volatility 15.1 % 15.2 % Probability of completing a Business Combination 88.3 % 88.3 % Term (in years) 5.88 6.00 Risk-free rate 0.49 % 0.51 %
Schedule of change in the fair value of the derivative warrant liabilities	The change in the fair value of the derivative warrant liabilities for the period ended December 31, 2020 is summarized as follows: Private Placement Public Placement Total Derivative Warrants Warrants Warrant Liabilities Initial measurement on November 19, 2020 $ 4,548,871 $ 3,904,107 $ 8,452,978 Change in fair value of derivative warrant liabilities 1,391,022 1,380,383 2,771,405 Derivative warrant liabilities at December 31, 2020 $ 5,939,893 $ 5,284,490 $ 11,224,383

ORGANIZATION AND DESCRIPTION _2

ORGANIZATION AND DESCRIPTION OF BUSINESS OPERATIONS (Details) - USD ($)	Dec. 31, 2020	Nov. 19, 2020	Dec. 31, 2020	Dec. 31, 2020
Subsidiary, Sale of Stock [Line Items]
Threshold period for option to purchase additional Units to cover over-allotments		45 days
Maximum number of units to be issued		1,500,000
Share price		$ 10.25
Proceeds from issuance of warrants			$ 5,817,757
Maturity term of U.S government securities			185 days
Assets held in trust		$ 107,100,000
Issuance of Class B common stock to Sponsor			$ 25,000
Assets held in trust, Price per Unit		$ 10.25
Minimum net tangible assets upon consummation of the Business Combination	$ 5,000,001		5,000,001	$ 5,000,001
Underwriting discount		$ 1,300,000
Working capital	1,200,000		$ 1,200,000	1,200,000
Operating bank accounts				990,000
Promissory Note				210,000
Initial public offering cost				$ 25,000
Deferred underwriting commissions		$ 3,400,000
Initial Public Offering
Subsidiary, Sale of Stock [Line Items]
Sale of 10,447,350 Units in November 2020 at $10.00 per Unit, net of derivative warrant liabilities (in shares)		10,447,350
Share price		$ 10
Gross proceeds		$ 104,500,000
Transaction costs		7,100,000
Deferred underwriting fees		3,400,000
Cash underwriting fees		1,300,000
Offering costs		$ 550,000
Investment of cash into Trust Account	$ 990,000
Number of shares exercisable to purchase per warrant		1
Exercise price of warrants		$ 11.50
Maturity term of U.S government securities			185 days
Issuance of Class B common stock to Sponsor		$ 1,800,000
Threshold minimum aggregate fair market value as a percentage of the assts held in the Trust Account			80.00%
Threshold percentage of public shares subject to redemption without the Company's prior written consent			50.00%
Redemption threshold as percent of outstanding		20.00%
Days for redemption of public shares			10 days
Obligation to redeem public shares if entity does not complete a business combination (as a percent)			100.00%
Maximum net interest to pay dissolution expenses		$ 100,000
Over-allotment
Subsidiary, Sale of Stock [Line Items]
Sale of 10,447,350 Units in November 2020 at $10.00 per Unit, net of derivative warrant liabilities (in shares)		447,350
Threshold period for option to purchase additional Units to cover over-allotments		45 days
Maximum number of units to be issued		1,500,000
Share price		$ 10
Gross proceeds		$ 4,500,000
Number of warrants issued	167,757	167,757	167,757	167,757
Proceeds from issuance of warrants		$ 170,000
Price per warrant		$ 1
Private Placement
Subsidiary, Sale of Stock [Line Items]
Number of warrants issued	5,817,757	5,650,000	5,817,757	5,817,757
Number of shares exercisable to purchase per warrant	1	1	1	1
Proceeds from issuance of warrants		$ 5,700,000	$ 5,800,000
Price per warrant		$ 1	$ 1
Exercise price of warrants	$ 11.50	$ 11.50	$ 11.50	$ 11.50
Class A common stock
Subsidiary, Sale of Stock [Line Items]
Issuance of Class B common stock to Sponsor			$ 107,100,000
Class A common stock | Initial Public Offering
Subsidiary, Sale of Stock [Line Items]
Sale of 10,447,350 Units in November 2020 at $10.00 per Unit, net of derivative warrant liabilities (in shares)		10,000,000
Gross proceeds		$ 100,000,000

RESTATEMENT OF PREVIOUSLY ISS_3

RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Details) - USD ($)	5 Months Ended
	Dec. 31, 2020	Nov. 19, 2020	Jul. 22, 2020
BALANCE SHEET
Class A common stock subject to possible redemption (at approximately $10.25 per share)	$ 107,085,338
Stockholders' equity (deficit)
Accumulated deficit	(13,441,493)
Total stockholders' equity/(deficit)	(13,441,213)		$ 0
Net tangible assets	5,000,001
Statement of Operations
Net loss	(3,280,790)
Revision of warrants as derivative liability and redeemable common stock as temporary equity
Stockholders' equity (deficit)
Accumulated deficit	(13,441,493)	$ (10,481,259)
Total stockholders' equity/(deficit)	(13,441,213)	(10,480,953)
Statement of Operations
Net loss	(3,280,790)
As Previously Reported | Revision of warrants as derivative liability and redeemable common stock as temporary equity
Stockholders' equity (deficit)
Additional paid-in capital	8,280,331	5,010,305
Accumulated deficit	(3,280,790)	(10,679)
Total stockholders' equity/(deficit)	5,000,001	5,000,001
Statement of Operations
Net loss	(3,280,790)
Supplemental Disclosure of Non-Cash Financing Activities:
Initial classification of common stock subject to possible redemption	100,057,362
Change in value of Class A common stock subject to possible redemption	(11,413,238)
Adjustment | Revision of warrants as derivative liability and redeemable common stock as temporary equity
Stockholders' equity (deficit)
Additional paid-in capital	(8,280,331)	(5,010,305)
Accumulated deficit	(10,160,703)	(10,470,580)
Total stockholders' equity/(deficit)	(18,441,214)	$ (15,480,954)
Supplemental Disclosure of Non-Cash Financing Activities:
Initial classification of common stock subject to possible redemption	(100,057,362)
Change in value of Class A common stock subject to possible redemption	11,413,238
Class A common stock
BALANCE SHEET
Class A common stock subject to possible redemption (at approximately $10.25 per share)	107,085,338
Stockholders' equity (deficit)
Common stock	$ 18
Shares subject to possible redemption	10,447,350	10.25
Common stock, par value	$ 0.0001	$ 0.0001
Temporary equity, par value	$ 10.25
Statement of Operations
Weighted average shares outstanding, basic	2,725,396
Weighted average shares outstanding, diluted	2,725,396
Basic net income / (loss) per share	$ (0.63)
Diluted net income / (loss) per share	$ (0.63)
Class A common stock | Revision of warrants as derivative liability and redeemable common stock as temporary equity
BALANCE SHEET
Class A common stock subject to possible redemption (at approximately $10.25 per share)	$ 107,085,338	$ 107,085,338
Stockholders' equity (deficit)
Common stock	18	18
Class A common stock | As Previously Reported | Revision of warrants as derivative liability and redeemable common stock as temporary equity
BALANCE SHEET
Class A common stock subject to possible redemption (at approximately $10.25 per share)	88,644,124	91,604,384
Stockholders' equity (deficit)
Common stock	$ 198	87
Statement of Operations
Weighted average shares outstanding, basic	10,630,179
Weighted average shares outstanding, diluted	10,630,179
Basic net income / (loss) per share	$ 0
Diluted net income / (loss) per share	$ 0
Class A common stock | Adjustment | Revision of warrants as derivative liability and redeemable common stock as temporary equity
BALANCE SHEET
Class A common stock subject to possible redemption (at approximately $10.25 per share)	$ 18,441,214	15,480,954
Stockholders' equity (deficit)
Common stock	$ (180)	$ (69)
Statement of Operations
Weighted average shares outstanding, basic	(10,630,179)
Weighted average shares outstanding, diluted	(10,630,179)
Basic net income / (loss) per share	$ 0
Diluted net income / (loss) per share	$ 0
Common stock Class A subject to possible redemption | Revision of warrants as derivative liability and redeemable common stock as temporary equity
Statement of Operations
Weighted average shares outstanding, basic	2,725,396
Weighted average shares outstanding, diluted	2,725,396
Basic net income / (loss) per share	$ (0.63)
Diluted net income / (loss) per share	$ (0.63)
Common stock Class A subject to possible redemption | Adjustment | Revision of warrants as derivative liability and redeemable common stock as temporary equity
Statement of Operations
Weighted average shares outstanding, basic	2,725,396
Weighted average shares outstanding, diluted	2,725,396
Basic net income / (loss) per share	$ (0.63)
Diluted net income / (loss) per share	$ (0.63)
Common stock Class A subject to not possible redemption | Revision of warrants as derivative liability and redeemable common stock as temporary equity
Statement of Operations
Weighted average shares outstanding, basic	2,481,084
Weighted average shares outstanding, diluted	2,481,084
Basic net income / (loss) per share	$ (0.63)
Diluted net income / (loss) per share	$ (0.63)
Common stock Class A subject to not possible redemption | Adjustment | Revision of warrants as derivative liability and redeemable common stock as temporary equity
Statement of Operations
Weighted average shares outstanding, basic	2,481,084
Weighted average shares outstanding, diluted	2,481,084
Basic net income / (loss) per share	$ (0.63)
Diluted net income / (loss) per share	$ (0.63)
Class B common stock
Stockholders' equity (deficit)
Common stock	$ 262
Common stock, par value	$ 0.0001	$ 0.0001
Class B common stock | Revision of warrants as derivative liability and redeemable common stock as temporary equity
Stockholders' equity (deficit)
Common stock	$ 262	$ 288
Class B common stock | As Previously Reported | Revision of warrants as derivative liability and redeemable common stock as temporary equity
Stockholders' equity (deficit)
Common stock	$ 262	$ 288
Statement of Operations
Weighted average shares outstanding, basic	2,531,315
Weighted average shares outstanding, diluted	2,531,315
Basic net income / (loss) per share	$ (1.30)
Diluted net income / (loss) per share	$ (1.30)
Class B common stock | Adjustment | Revision of warrants as derivative liability and redeemable common stock as temporary equity
Statement of Operations
Weighted average shares outstanding, basic	(2,531,315)
Weighted average shares outstanding, diluted	(2,531,315)
Basic net income / (loss) per share	$ 1.30
Diluted net income / (loss) per share	$ 1.30

SIGNIFICANT ACCOUNTING POLICI_4

SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)	5 Months Ended
	Dec. 31, 2020	Nov. 19, 2020
Subsidiary, Sale of Stock [Line Items]
Cash	$ 0
Offering costs associated with warrants recorded as liabilities	309,851
Offering costs	8,500,000
Federal depository insurance corporation limit	$ 250,000
Maturity term of U.S government securities	185 days
Unrecognized tax benefits	$ 0
Unrecognized tax benefits accrued for interest and penalties	0
Working capital	$ 1,200,000
Assets held in trust		$ 107,100,000
Class A common stock
Subsidiary, Sale of Stock [Line Items]
Number of shares issued	10,447,350	10.25
Public Warrants
Subsidiary, Sale of Stock [Line Items]
Warrants outstanding	5,223,675
Private Placement Warrants
Subsidiary, Sale of Stock [Line Items]
Warrants outstanding	5,817,757
Initial Public Offering
Subsidiary, Sale of Stock [Line Items]
Maturity term of U.S government securities	185 days
Initial Public Offering | Class A common stock
Subsidiary, Sale of Stock [Line Items]
Warrants outstanding	11,041,432

SIGNIFICANT ACCOUNTING POLICI_5

SIGNIFICANT ACCOUNTING POLICIES - Shares of Class A common stock reflected on the balance sheet (Details)	5 Months Ended
	Dec. 31, 2020USD ($)
Class A common stock subject to possible redemption, 141,181,096 shares at redemption value	$ 107,085,338
Class A common stock
Gross proceeds	104,473,500
Proceeds allocated to public warrants	(3,904,107)
Class A shares issuance costs	(4,940,543)
Accretion of carrying value to redemption value	11,456,488
Class A common stock subject to possible redemption, 141,181,096 shares at redemption value	$ 107,085,338

SIGNIFICANT ACCOUNTING POLICI_6

SIGNIFICANT ACCOUNTING POLICIES - Net income per share of common stock (Details)	5 Months Ended
	Dec. 31, 2020USD ($)$ / sharesshares
Class A common stock
Denominator:
Basic weighted-average shares outstanding | shares	2,725,396
Diluted weighted-average shares outstanding | shares	2,725,396
Basic net loss per share | $ / shares	$ (0.63)
Diluted net loss per share | $ / shares	$ (0.63)
Redeemable Shares Member
Numerator:
Allocation of net loss | $	$ (1,717,370)
Denominator:
Basic weighted-average shares outstanding | shares	2,725,396
Diluted weighted-average shares outstanding | shares	2,725,396
Basic net loss per share | $ / shares	$ (0.63)
Diluted net loss per share | $ / shares	$ (0.63)
Non Redeemable Shares Member
Numerator:
Allocation of net loss | $	$ (1,563,420)
Denominator:
Basic weighted-average shares outstanding | shares	2,481,084
Diluted weighted-average shares outstanding | shares	2,481,084
Basic net loss per share | $ / shares	$ (0.63)
Diluted net loss per share | $ / shares	$ (0.63)
Non-redeemable common stock
Denominator:
Basic weighted-average shares outstanding | shares	2,481,084	[1]
Diluted weighted-average shares outstanding | shares	2,481,084	[1]
Basic net loss per share | $ / shares	$ (0.63)
Diluted net loss per share | $ / shares	$ (0.63)
[1]	For the period from July 23, 2020 (inception) through December 31, 2020, the basic and diluted weighted average non-redeemable common stock outstanding consisted of 47,695 shares of Class A common stock and 2,611,838 shares of Class B common stock.

INITIAL PUBLIC OFFERING (Detail

INITIAL PUBLIC OFFERING (Details) $ / shares in Units, $ in Millions	Nov. 19, 2020USD ($)$ / sharesshares
Subsidiary, Sale of Stock [Line Items]
Share price | $ / shares	$ 10.25
Initial Public Offering
Subsidiary, Sale of Stock [Line Items]
Sale of 10,447,350 Units in November 2020 at $10.00 per Unit, net of derivative warrant liabilities (in shares)	10,447,350
Share price | $ / shares	$ 10
Gross proceeds | $	$ 104.5
Number of unit consists class A ordinary shares	1
Shares issuable per warrant	1
Number of warrants issued per unit	0.5
Exercise price of warrants | $ / shares	$ 11.50
Over-allotment
Subsidiary, Sale of Stock [Line Items]
Sale of 10,447,350 Units in November 2020 at $10.00 per Unit, net of derivative warrant liabilities (in shares)	447,350
Share price | $ / shares	$ 10
Gross proceeds | $	$ 4.5

PRIVATE PLACEMENT WARRANTS (Det

PRIVATE PLACEMENT WARRANTS (Details) - USD ($)	Nov. 19, 2020	Dec. 31, 2020
Subsidiary, Sale of Stock [Line Items]
Proceeds from issuance of warrants		$ 5,817,757
Private Placement
Subsidiary, Sale of Stock [Line Items]
Number of warrants issued	5,650,000	5,817,757
Shares issuable per warrant	1	1
Exercise price of warrants	$ 11.50	$ 11.50
Price per warrant	$ 1	$ 1
Proceeds from issuance of warrants	$ 5,700,000	$ 5,800,000
Over-allotment
Subsidiary, Sale of Stock [Line Items]
Number of warrants issued	167,757	167,757
Price per warrant	$ 1
Proceeds from issuance of warrants	$ 170,000

RELATED PARTY TRANSACTIONS - Fo

RELATED PARTY TRANSACTIONS - Founder Shares (Details) - USD ($)	Dec. 21, 2020	Nov. 19, 2020	Nov. 17, 2020	Oct. 25, 2020	Aug. 03, 2020	Dec. 31, 2020	Nov. 16, 2020
Related Party Transaction [Line Items]
Aggregate purchase price						$ 25,000
Over-allotment
Related Party Transaction [Line Items]
Sale of units (in shares)		447,350
Sponsor | Private Placement | Founder Shares
Related Party Transaction [Line Items]
Stock price trigger to transfer, assign or sell any shares or warrants of the company, after the completion of the initial business combination (in dollars per share)						$ 12
Class B common stock
Related Party Transaction [Line Items]
Number of shares issued					7,187,500
Aggregate purchase price					$ 25,000
Common stock, shares outstanding						2,611,838
Common stock, shares issued						2,611,838
Class B common stock | Founder Shares
Related Party Transaction [Line Items]
Threshold period after the business combination in which the 20 trading days within any 30 trading day period commences						150 days
Class B common stock | Over-allotment
Related Party Transaction [Line Items]
Shares subject to forfeiture				375,000
Percentage of issued and outstanding shares held by initial stockholders				20.00%		20.00%
Number of shares were forfeited	263,162
Class B common stock | Over-allotment | Founder Shares
Related Party Transaction [Line Items]
Common stock, shares outstanding	2,611,838
Common stock, shares issued	2,611,838
Class B common stock | Sponsor
Related Party Transaction [Line Items]
Shares surrendered			431,250	3,881,250
Consideration for shares surrender			$ 0	$ 0
Common stock, shares outstanding			2,875,000	7,187,500			3,306,250
Class B common stock | Sponsor | Maximum
Related Party Transaction [Line Items]
Common stock, shares outstanding				3,306,250

RELATED PARTY TRANSACTIONS - Ad

RELATED PARTY TRANSACTIONS - Additional information (Details) - USD ($)	Nov. 19, 2020	Jul. 23, 2020	Dec. 31, 2020
Related Party Transaction [Line Items]
Repayments of Related Party Debt			$ 205,991
Promissory Note With Related Party
Related Party Transaction [Line Items]
Repayments of Related Party Debt	$ 205,991
Sponsor | Unsecured Promissory Note | Promissory Note With Related Party
Related Party Transaction [Line Items]
Face amount		$ 300,000
Related Party Loans
Related Party Transaction [Line Items]
Maximum loans converted into warrants			2,500,000
Administrative Support Agreement
Related Party Transaction [Line Items]
Expenses per month			$ 10,000
Period for use of office space, utilities and secretarial and administrative support			18 months
Total expenses incurred and paid			$ 20,000

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Details) $ / shares in Units, $ in Millions	Nov. 19, 2020USD ($)$ / sharesshares
COMMITMENTS AND CONTINGENCIES
Underwriting option period	45 days
Number of units granted to underwriters | shares	1,500,000
Underwriting discount, per unit | $ / shares	$ 0.125
Underwriting discount | $	$ 1.3
Deferred fee per unit | $ / shares	$ 0.325
Deferred underwriting commissions | $	$ 3.4

COMMITMENTS AND CONTINGENCIES -

COMMITMENTS AND CONTINGENCIES - Representative common stock (Details) $ / shares in Units, $ in Millions	Nov. 19, 2020USD ($)$ / sharesshares
Commitments And Contingencies [Line Items]
Share price per share	$ 10.25
Maxim Partners LLC | Class A common stock
Commitments And Contingencies [Line Items]
Number of shares issued | shares	182,829
Threshold period in which the entity will waive its rights to liquidate distributions from the Trust Account if the Company fails to complete its initial Business Combination	18 months
Share price per share	$ 10
Fair value of shares of common stock | $	$ 1.8

STOCKHOLDERS DEFICIT - Preferen

STOCKHOLDERS DEFICIT - Preference Shares (Details)	Dec. 31, 2020$ / sharesshares
STOCKHOLDERS' DEFICIT
Preferred shares, shares authorized	1,000,000
Preferred shares, par value | $ / shares	$ 0.0001
Preferred stock, shares issued	0
Preferred stock, shares outstanding	0

STOCKHOLDERS DEFICIT - Ordinary

STOCKHOLDERS DEFICIT - Ordinary Shares (Details) - USD ($)	Aug. 03, 2020	Dec. 31, 2020	Nov. 19, 2020	Nov. 17, 2020	Nov. 16, 2020	Oct. 25, 2020
Class of Stock [Line Items]
Aggregate purchase price		$ 25,000
Number of Class A common stock issued upon conversion of each share (in shares)		1
Number of common stock issuable upon conversion pursuant to Initial Business Combination, as a percent of outstanding shares		20.00%
Class A common stock
Class of Stock [Line Items]
Common stock, shares authorized		100,000,000
Common stock, par value		$ 0.0001	$ 0.0001
Common stock, shares issued		182,829
Common stock, shares outstanding		182,829
Common stock, shares issued including redemption		182,829
Common stock, shares outstanding including redemption		182,829
Shares subject to possible redemption		10,447,350	10.25
Aggregate purchase price		$ 107,100,000
Common stock subject to possible redemption (in shares)		10,447,350
Class B common stock
Class of Stock [Line Items]
Common stock, shares authorized		10,000,000
Common stock, par value		$ 0.0001	$ 0.0001
Common stock, shares issued		2,611,838
Common stock, shares outstanding		2,611,838
Aggregate purchase price	$ 25,000
Common shares, votes per share		$ 1
Class B common stock | Sponsor
Class of Stock [Line Items]
Common stock, shares outstanding				2,875,000	3,306,250	7,187,500

DERIVATIVE WARRANT LIABILITIES

DERIVATIVE WARRANT LIABILITIES (Details)	5 Months Ended
	Dec. 31, 2020DUSD ($)$ / sharesshares	Nov. 19, 2020$ / shares
Class of Warrant or Right [Line Items]
Threshold business days before sending notice of redemption to warrant holders	20 days
Share price		$ 10.25
Public Warrants
Class of Warrant or Right [Line Items]
Warrants outstanding | shares	5,223,675
Threshold period for filling registration statement after business combination	30 days
Maximum Threshold Period For Registration Statement To Become Effective After Business Combination	12 months
Stock price trigger for redemption of public warrants (in dollars per share)	$ 18
Redemption price per public warrant (in dollars per share)	$ 0.01
Minimum threshold written notice period for redemption of public warrants	30 days
Threshold trading days for redemption of public warrants | D	20
Threshold consecutive trading days for redemption of public warrants | $	30
Threshold business days before sending notice of redemption to warrant holders	3 days
Share price	$ 9.20
Percentage of gross proceeds on total equity proceeds	60.00%
Adjustment of exercise price of warrants based on market value and newly issued price (as a percent)	115.00%
Adjustment of redemption price of stock based on market value and newly issued price 1 (as a percent)	180.00%
Private Placement Warrants
Class of Warrant or Right [Line Items]
Warrants outstanding | shares	5,817,757

INCOME TAX - Income Tax Provisi

INCOME TAX - Income Tax Provision (Details)	5 Months Ended
	Dec. 31, 2020USD ($)
Income tax provision for federal and state
Deferred	$ 40,502
Deferred	6,666
Change in valuation allowance	(47,168)
Income tax provision	$ 0

INCOME TAX - Net Deferred Tax A

INCOME TAX - Net Deferred Tax Assets (Details)	Dec. 31, 2020USD ($)
INCOME TAX
Deferred tax asset	$ 47,168
Valuation allowance	(47,168)
Deferred tax asset, net of allowance	0
Net operating loss carryforwards	$ 79,419

INCOME TAX - Reconciliation of

INCOME TAX - Reconciliation of the Federal Income Tax Rate to the Company's Effective Tax Rate (Details)	5 Months Ended
	Dec. 31, 2020
INCOME TAX
Statutory federal income tax rate	21.00%
State taxes, net of federal tax benefit	3.52%
Change in fair value of the derivative warrant liabilities	(17.70%)
Offering costs	(2)
Change in valuation allowance	(4.82%)
Income tax provision benefit	0.00%

FAIR VALUE MEASUREMENTS - Asset

FAIR VALUE MEASUREMENTS - Assets that are Measured at Fair Value on Recurring Basis (Details)	Dec. 31, 2020USD ($)
Liabilities:
Derivative warrant liabilities	$ 11,224,383
Recurring | Level 1
Assets:
Assets held in Trust Account	106,966,830
Recurring | Level 1 | U.S. Treasury securities
Assets:
Assets held in Trust Account	106,966,830
Recurring | Level 3
Liabilities:
Derivative warrant liabilities	11,224,383
Recurring | Level 3 | Public Warrants
Liabilities:
Derivative warrant liabilities	5,284,490
Recurring | Level 3 | Private Placement Warrants
Liabilities:
Derivative warrant liabilities	$ 5,939,893

FAIR VALUE MEASUREMENTS (Detail

FAIR VALUE MEASUREMENTS (Details)	1 Months Ended	5 Months Ended
	Dec. 31, 2020USD ($)	Dec. 31, 2020USD ($)
FAIR VALUE MEASUREMENTS
Transfers from Level 1 to Level 2	$ 0	$ 0
Transfers from Level 2 to Level 1	0	0
Transfers into level 3		0
Transfers out of level 3		0
Change in fair value of derivative warrant liabilities	2,771,405	2,800,000
cash held in trust account	$ 127,663	$ 127,663

FAIR VALUE MEASUREMENTS - Measu

FAIR VALUE MEASUREMENTS - Measurements Inputs (Details)	Dec. 31, 2020Y$ / shares	Nov. 19, 2020Y$ / shares
Exercise price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative Liability, Measurement Input	11.50	11.50
Stock price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative Liability, Measurement Input	10.30	9.63
Volatility
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative Liability, Measurement Input	15.1	15.2
Probability of completing a Business Combination
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative Liability, Measurement Input	88.3	88.3
Term (in years)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative Liability, Measurement Input | Y	5.88	6
Risk-free rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative Liability, Measurement Input	0.49	0.51

FAIR VALUE MEASUREMENTS - Chang

FAIR VALUE MEASUREMENTS - Change In Fair Value of Derivative Warrant Liabilities (Details) - USD ($)	1 Months Ended	5 Months Ended
	Dec. 31, 2020	Dec. 31, 2020
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Derivative warrant liabilities at December 31, 2020	$ 8,452,978
Change in fair value of derivative warrant liabilities	2,771,405	$ 2,800,000
Derivative warrant liabilities at September 30, 2021	11,224,383	11,224,383
Public Warrants
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Derivative warrant liabilities at December 31, 2020	3,904,107
Change in fair value of derivative warrant liabilities	1,380,383
Derivative warrant liabilities at September 30, 2021	5,284,490	5,284,490
Private Placement Warrants
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Derivative warrant liabilities at December 31, 2020	4,548,871
Change in fair value of derivative warrant liabilities	1,391,022
Derivative warrant liabilities at September 30, 2021	$ 5,939,893	$ 5,939,893